UNSPSC 51284717: Azamulin

This classification denotes an antimicrobial with the molecular formula C24H38N4O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 875AQ866X1, chemically known as ((5-amino-s-triazol-3-yl)thio)acetic acid, 8-ester with (3as,4r,5s,6r,8r,9ar,10r)-6-ethyloctahydro-5,8-dihydroxy-4,6,9,10-tetramethyl-3a,9-propano-3ah-cyclopentacycloocten-1(4h)-one but more generally known as azamulin, which bears US NIH Compound Identifier 3086060.

UNSPSC 51284717 Azamulin is a Commodity code with minimal recent state and local procurement activity. The source contains no open solicitations tagged to this code; the records reflect a completed pharmaceutical warehouse award and a drug-deactivation procurement that do not align with azamulin procurement. Azamulin is a macrolide antibiotic used in human medicine and animal health applications, yet the recent opportunities record shows Illinois Department of Public Health and Seminole County, Florida sourcing other pharmaceutical products (doxycycline hyclate, ciprofloxacin hydrochloride, and naloxone) through piggyback and competitive bidding channels, not azamulin itself. The mismatch between the code designation and the actual commodities in the opportunity records suggests either tagging inconsistency or that azamulin procurement, if it occurs at the state and local level, does not generate sufficient recent solicitation volume to surface in current market activity.

The source provides no current open solicitations, active RFPs, RFQs, ITBs, or IFBs for azamulin under this code. Firms evaluating pursuit should confirm whether azamulin is actually procured through standard state and local pharmaceutical channels or reserve purchasing vehicles such as MMCAP Infuse (as shown in the Illinois award) before investing business development resources. If azamulin demand exists at the state or local level, it may flow through existing piggyback contracts, standing state health department agreements, or cooperative purchasing consortia rather than as discrete solicitations.